NEW YORK (GenomeWeb News) – Nuclea Biotechnologies today announced a research and collaboration agreement with Berkshire Medical Center aimed at prostate cancer and breast cancer biomarker identification.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.